Real-time enrollment status for this myelodysplastic syndromes clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 9:10 AM UTC
| NCT Number | NCT06499285 |
| Recruiting Status | Recruiting |
| Condition | Myelodysplastic Syndromes |
| Phase | PHASE3 |
| Target Enrollment | 225 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Takeda |
| Last Updated on CT.gov | August 21, 2026 (1 week ago) |
As of September 1, 2026: Clinical trial NCT06499285 is currently recruiting participants. This phase3 study for myelodysplastic syndromes is actively seeking new participants at 22 locations across the United States. The study is sponsored by Takeda. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06499285 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06499285 was last updated 1 week ago (August 21, 2026). HelloStudys verifies this status automatically.